Healthcare provider profile · identity verified

Ryan Miller, MD

Internal Medicine · SIOUX FALLS, SD · NPI 1639597693

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	420	101
Rosuvastatin Calcium	Rosuvastatin Calcium	382	85
Losartan Potassium	Losartan Potassium	381	88
Levothyroxine Sodium	Levothyroxine Sodium	371	73
Omeprazole	Omeprazole	277	68
Amlodipine Besylate	Amlodipine Besylate	263	69
Gabapentin	Gabapentin	250	46
Lisinopril	Lisinopril	240	65
Metoprolol Succinate	Metoprolol Succinate	199	51
Potassium Chloride	Potassium Chloride	179	37
Pantoprazole Sodium	Pantoprazole Sodium	178	40
Metformin Hcl Er	Metformin Hcl	160	31
Trazodone Hcl	Trazodone Hcl	153	33
Furosemide	Furosemide	150	38
Alendronate Sodium	Alendronate Sodium	134	32
Carvedilol	Carvedilol	130	33
Tamsulosin Hcl	Tamsulosin Hcl	130	40
Metformin Hcl	Metformin Hcl	127	27
Eliquis	Apixaban	124	25
Sertraline Hcl	Sertraline Hcl	118	28
Hydrochlorothiazide	Hydrochlorothiazide	117	31
Simvastatin	Simvastatin	114	25
Escitalopram Oxalate	Escitalopram Oxalate	102	25
Allopurinol	Allopurinol	100	23
Clopidogrel	Clopidogrel Bisulfate	99	14
Baclofen	Baclofen	97	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	28
Prednisone	Prednisone	93	68
Duloxetine Hcl	Duloxetine Hcl	82	18
Fluoxetine Hcl	Fluoxetine Hcl	80	suppressed
Spironolactone	Spironolactone	74	20
Tramadol Hcl	Tramadol Hcl	70	17
Montelukast Sodium	Montelukast Sodium	68	21
Famotidine	Famotidine	67	13
Metoprolol Tartrate	Metoprolol Tartrate	67	18
Pravastatin Sodium	Pravastatin Sodium	65	19
Clonazepam	Clonazepam	64	suppressed
Januvia	Sitagliptin Phosphate	62	suppressed
Jardiance	Empagliflozin	61	17
Ozempic	Semaglutide	59	11
Ezetimibe	Ezetimibe	56	15
Oxycodone Hcl	Oxycodone Hcl	55	14
Bumetanide	Bumetanide	53	suppressed
Atenolol	Atenolol	51	suppressed
Buspirone Hcl	Buspirone Hcl	51	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	11
Bupropion Xl	Bupropion Hcl	48	12
Finasteride	Finasteride	48	11
Celecoxib	Celecoxib	46	suppressed
Mirtazapine	Mirtazapine	46	suppressed
Warfarin Sodium	Warfarin Sodium	46	13
Amitriptyline Hcl	Amitriptyline Hcl	45	12
Pregabalin	Pregabalin	44	suppressed
Myrbetriq	Mirabegron	43	suppressed
Glimepiride	Glimepiride	42	11
Torsemide	Torsemide	42	11
Synthroid	Levothyroxine Sodium	40	12
Chlorthalidone	Chlorthalidone	38	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	14
Albuterol Sulfate Hfa	Albuterol Sulfate	35	21
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Irbesartan	Irbesartan	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Trulicity	Dulaglutide	30	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	29	suppressed
Divalproex Sodium	Divalproex Sodium	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	13
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Lorazepam	Lorazepam	22	11
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Fentanyl	Fentanyl	20	suppressed
Risperidone	Risperidone	20	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Topiramate	Topiramate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Cefdinir	Cefdinir	18	17
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Metolazone	Metolazone	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	15	15
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fiasp	Insulin Aspart (Niacinamide)	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Temazepam	Temazepam	13	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error